A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing

NCT01808612 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Fluoxetine
DRUG: Placebo

Sponsor

Eli Lilly and Company